T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Progress Software
PRGS
$1.79B
| $90.2M | 0.02% |
3,319,227
-84,663
| -2% | -$2.24M |
|
652
Dover
DOV
$28B
| $89.6M | 0.02% |
1,605,176
+1,269,153
| +378% | +$73.1M |
|
|
TNGO
653
DELISTED
Tangoe, Inc.
TNGO
| $89.5M | 0.02% |
6,487,720
+138,350
| +2% | +$1.7M |
|
654
Genworth Financial
GNW
$3.79B
| $89.2M | 0.02% |
12,200,072
+4,010,685
| +49% | +$30.5M |
|
655
Pool Corp
POOL
$7.25B
| $88.7M | 0.02% |
1,270,829
-85,670
| -6% | -$5.72M |
|
656
Align Technology
ALGN
$12.4B
| $88.4M | 0.02% |
1,643,651
-2,448,234
| -60% | -$140M |
|
657
TD Synnex
SNX
$20.4B
| $88M | 0.02% |
2,278,220
-539,000
| -19% | -$20.7M |
|
658
Tenaris
TS
$26.8B
| $86.9M | 0.02% |
3,102,228
-571,020
| -16% | -$16.3M |
|
659
LCI Industries
LCII
$2.6B
| $86.4M | 0.02% |
1,404,730
-284,050
| -17% | -$15.6M |
|
|
ATRI
660
DELISTED
Atrion Corp
ATRI
| $85.6M | 0.02% |
247,697
+25,429
| +11% | +$8.49M |
|
661
Boston Beer
SAM
$1.89B
| $85.5M | 0.02% |
319,829
+28,221
| +10% | +$8.18M |
|
662
Mativ Holdings
MATV
$690M
| $85M | 0.02% |
1,843,389
+56,050
| +3% | +$2.43M |
|
663
Bright Horizons
BFAM
$3.76B
| $84.9M | 0.02% |
1,656,196
+741,896
| +81% | +$36.9M |
|
664
Healthcare Services Group
HCSG
$1.43B
| $84.6M | 0.02% |
2,632,260
+72,008
| +3% | +$2.33M |
|
665
Eagle Materials
EXP
$6.47B
| $83.9M | 0.02% |
1,003,515
-18,490
| -2% | -$1.44M |
|
|
ENV
666
DELISTED
ENVESTNET, INC.
ENV
| $83.5M | 0.02% |
1,489,351
+962,651
| +183% | +$51.4M |
|
|
ACC
667
DELISTED
American Campus Communities, Inc.
ACC
| $82.8M | 0.02% |
1,931,166
+503,140
| +35% | +$21.5M |
|
|
CNL
668
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $82.7M | 0.02% |
1,516,920
-734,440
| -33% | -$40M |
|
|
CRAY
669
DELISTED
Cray, Inc.
CRAY
| $82.5M | 0.02% |
2,937,437
+234,230
| +9% | +$7.43M |
|
670
Sempra
SRE
$56.2B
| $82.3M | 0.02% |
1,509,654
+102,718
| +7% | +$5.66M |
|
|
HAPN
671
Happen Inc
HAPN
$2.25B
| $81.8M | 0.02% |
853,987
+21,095
| +3% | +$2.2M |
|
|
HUB.B
672
DELISTED
HUBBELL INC CL-B
HUB.B
| $81.7M | 0.02% |
745,498
-71,708
| -9% | -$7.87M |
|
673
Revvity
RVTY
$13.2B
| $81.6M | 0.02% |
1,594,946
+1,408,537
| +756% | +$65.2M |
|
674
NextEra Energy
NEE
$179B
| $81.4M | 0.02% |
3,129,332
+175,680
| +6% | +$4.63M |
|
|
RAVN
675
DELISTED
Raven Industries Inc
RAVN
| $81.3M | 0.02% |
3,973,124
-769,476
| -16% | -$16.6M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.